Skip to main content
Gentian Diagnostics ASA logo

Gentian Diagnostics ASA — Investor Relations & Filings

Ticker · GENT ISIN · NO0010748866 LEI · 5967007LIEEXZXHNM861 OL Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2017-03-22 Earnings Release
Country NO Norway
Listing OL GENT

About Gentian Diagnostics ASA

https://www.gentian.com/

Gentian Diagnostics ASA is a medical diagnostics company that develops, manufactures, and markets innovative in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for open clinical chemistry platforms, aiming to enhance laboratory efficiency and support better clinical treatment decisions. Its portfolio and pipeline of diagnostic tests address biomarkers in high-impact medical areas, including kidney disease, cardiac disease, inflammation, and infection. Key products include assays for Cystatin C, NGAL, and Calprotectin. In addition to its human diagnostics portfolio, the company provides diagnostic solutions for the veterinary market. Gentian serves a global customer base through original equipment manufacturer (OEM) partners, distributors, and healthcare providers.

Recent filings

Filing Released Lang Actions
UPDATE ON SITUATION IN CHINA
Earnings Release Classification · 99% confidence The document is a short update titled "UPDATE ON SITUATION IN CHINA" referencing previous stock exchange announcements and providing commentary from the CEO regarding a distributor issue and positive R&D news (G-1001 proof of concept). It is not a full financial report (10-K, IR, ER) nor a formal proxy/governance document. Given its nature as a timely, specific operational update released via the stock exchange mechanism (implied by referencing previous announcements and the company being listed on OSE), it fits best as a general Regulatory Filing (RNS) or potentially an operational announcement that doesn't fit the other specific categories. Since it is a direct, non-financial-summary announcement about business operations and outlook, RNS is the most appropriate fallback category. FY 2017
2017-03-22 English
GENTIAN ACHIEVES PROOF-OF-CONCEPT ON G-1001 AND PROVIDES A COMPANY UPDATE
Regulatory Filings Classification · 100% confidence The document is a short announcement titled 'GENTIAN ACHIEVES PROOF-OF-CONCEPT ON G-1001 AND PROVIDES A COMPANY UPDATE'. It details R&D milestones (Proof of Concept for G-1001 and Nanosense II) and provides a brief update on expected Q1 2017 revenues due to a delay in the Chinese market. The length is short (3938 chars) and it functions as a general update on company progress and minor financial guidance revision, rather than a full financial report (10-K, IR) or a formal earnings release (ER) which typically contains detailed quarterly figures. Since it is a general operational and financial update that doesn't fit the specific categories like ER, DIV, or CAP, and it is not a formal regulatory filing like a 10-K, the most appropriate classification is a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if the revenue guidance update is the primary focus. Given the strong focus on R&D milestones and the brief revenue guidance revision, it aligns best with a general regulatory announcement or update. Since it is not a formal Earnings Release (ER) which usually contains the full quarterly results summary, RNS (Regulatory Filings) serves as the best general category for this type of operational news release.
2017-03-22 English
GENTIAN DIAGNOSTICS APPOINTS DR ALEKSANDRA MANDIC HAVELKA AS MANAGING DIRECTOR OF ITS SWEDISH SUBSIDUARY: GENTIAN DIAGNOSTICS AB
Board/Management Information Classification · 99% confidence The document is a press release dated March 8, 2017, announcing the appointment of Dr. Aleksandra Mandic Havelka as the Managing Director of the Swedish subsidiary, Gentian Diagnostics AB. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). The document is short and clearly an announcement, not a comprehensive report.
2017-03-08 English
Q4 2016 Financial Report and Preliminary Annual Report
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the fourth quarter and the full year 2016, titled 'Interim Report' and 'Preliminary Annual Report'. It contains detailed financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, and Cash Flow Statement, along with management commentary on operational status, financial performance, and outlook. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year (Q4) and preliminary annual figures. Q4 2016
2017-02-15 English
Q4 2016 Financial Report and Preliminary Annual Report
Report Publication Announcement Classification · 98% confidence The document explicitly states it is announcing the 'Q4 2016 Financial Report and Preliminary Annual Report' and provides key highlights. Crucially, it ends with the statement: 'Please find the report for the fourth quarter enclosed. The report will also be made available on www.gentian.no.' Given the very short document length (1038 chars) and the clear indication that the full report is enclosed/attached rather than being the full content itself, this fits the definition of a Report Publication Announcement (RPA) according to Rule 2, which covers announcements stating a report is attached or published. While it contains earnings highlights, the primary function here is the announcement of the attached report, making RPA the most precise classification over ER or IR.
2017-02-15 English
Q4 2016 Financial Report and Preliminary Annual Report
Earnings Release Classification · 100% confidence The document explicitly states it announces 'results for the fourth quarter and preliminary results for the full year of 2016' and provides key financial highlights (Total revenues of MNOK 31.0). This strongly suggests an Earnings Release (ER). However, the document is very short (982 characters) and concludes with 'Please find the report for the fourth quarter enclosed.' This structure—a brief summary announcing results and directing the reader to an enclosed/attached full report—fits the definition of an Earnings Release (ER) which provides initial highlights, or potentially a Report Publication Announcement (RPA) if the focus is purely on the publication act. Given the content is the actual summary of Q4 results and preliminary annual results, ER is the primary classification. If the document were only announcing the release date, RPA would be chosen. Since it contains the highlights, ER is more appropriate than RPA, but it is not the comprehensive 'IR' or '10-K'. Q4 2016
2017-02-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.